Literature DB >> 28237819

The Complex Roles of Mechanistic Target of Rapamycin in Adipocytes and Beyond.

Peter L Lee1, Su Myung Jung1, David A Guertin2.   

Abstract

Having healthy adipose tissue is essential for metabolic fitness. This is clear from the obesity epidemic, which is unveiling a myriad of comorbidities associated with excess adipose tissue including type 2 diabetes, cardiovascular disease, and cancer. Lipodystrophy also causes insulin resistance, emphasizing the importance of having a balanced amount of fat. In cells, the mechanistic target of rapamycin (mTOR) complexes 1 and 2 (mTORC1 and mTORC2, respectively) link nutrient and hormonal signaling with metabolism, and recent studies are shedding new light on their in vivo roles in adipocytes. In this review, we discuss how recent advances in adipose tissue and mTOR biology are converging to reveal new mechanisms that maintain healthy adipose tissue, and discuss ongoing mysteries of mTOR signaling, particularly for the less understood complex mTORC2.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28237819      PMCID: PMC5682923          DOI: 10.1016/j.tem.2017.01.004

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  191 in total

1.  Constitutive adipocyte mTORC1 activation enhances mitochondrial activity and reduces visceral adiposity in mice.

Authors:  Juliana Magdalon; Patricia Chimin; Thiago Belchior; Rodrigo X Neves; Marcel A Vieira-Lara; Maynara L Andrade; Talita S Farias; Andressa Bolsoni-Lopes; Vivian A Paschoal; Alex S Yamashita; Alicia J Kowaltowski; William T Festuccia
Journal:  Biochim Biophys Acta       Date:  2016-02-27

2.  mTORC2 Puts Its Shoulder to Krebs' Wheel.

Authors:  Sebastian I Arriola Apelo; Dudley W Lamming
Journal:  Mol Cell       Date:  2016-09-01       Impact factor: 17.970

3.  Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCF(Fbw7).

Authors:  Anders Sundqvist; Maria T Bengoechea-Alonso; Xin Ye; Vasyl Lukiyanchuk; Jianping Jin; J Wade Harper; Johan Ericsson
Journal:  Cell Metab       Date:  2005-06       Impact factor: 27.287

4.  New-Onset Diabetes Mellitus Associated with Sirolimus Use in Renal Transplant Recipients.

Authors:  Vural Taner Yilmaz; Huseyin Kocak; Ayhan Dinckan; Ramazan Cetinkaya
Journal:  Eurasian J Med       Date:  2015-10

5.  Mitochondrial uncoupling protein from mouse brown fat. Molecular cloning, genetic mapping, and mRNA expression.

Authors:  A Jacobsson; U Stadler; M A Glotzer; L P Kozak
Journal:  J Biol Chem       Date:  1985-12-25       Impact factor: 5.157

6.  Structure of the human mTOR complex I and its implications for rapamycin inhibition.

Authors:  Calvin K Yip; Kazuyoshi Murata; Thomas Walz; David M Sabatini; Seong A Kang
Journal:  Mol Cell       Date:  2010-06-11       Impact factor: 17.970

7.  New-onset diabetes after renal transplantation: risk assessment and management.

Authors:  Lidia Ghisdal; Steven Van Laecke; Marc J Abramowicz; Raymond Vanholder; Daniel Abramowicz
Journal:  Diabetes Care       Date:  2012-01       Impact factor: 19.112

8.  Characterization of Cre recombinase models for the study of adipose tissue.

Authors:  Elise Jeffery; Ryan Berry; Christopher D Church; Songtao Yu; Brett A Shook; Valerie Horsley; Evan D Rosen; Matthew S Rodeheffer
Journal:  Adipocyte       Date:  2014-06-27       Impact factor: 4.534

9.  Adipocytes arise from multiple lineages that are heterogeneously and dynamically distributed.

Authors:  Joan Sanchez-Gurmaches; David A Guertin
Journal:  Nat Commun       Date:  2014-06-19       Impact factor: 14.919

10.  Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis.

Authors:  Pengda Liu; Wenjian Gan; Hiroyuki Inuzuka; Adam S Lazorchak; Daming Gao; Omotooke Arojo; Dou Liu; Lixin Wan; Bo Zhai; Yonghao Yu; Min Yuan; Byeong Mo Kim; Shavali Shaik; Suchithra Menon; Steven P Gygi; Tae Ho Lee; John M Asara; Brendan D Manning; John Blenis; Bing Su; Wenyi Wei
Journal:  Nat Cell Biol       Date:  2013-10-27       Impact factor: 28.824

View more
  20 in total

Review 1.  Integrating adipocyte insulin signaling and metabolism in the multi-omics era.

Authors:  C Martinez Calejman; W G Doxsey; D J Fazakerley; D A Guertin
Journal:  Trends Biochem Sci       Date:  2022-03-15       Impact factor: 14.264

2.  Brown Fat AKT2 Is a Cold-Induced Kinase that Stimulates ChREBP-Mediated De Novo Lipogenesis to Optimize Fuel Storage and Thermogenesis.

Authors:  Joan Sanchez-Gurmaches; Yuefeng Tang; Naja Zenius Jespersen; Martina Wallace; Camila Martinez Calejman; Sharvari Gujja; Huawei Li; Yvonne J K Edwards; Christian Wolfrum; Christian M Metallo; Søren Nielsen; Camilla Scheele; David A Guertin
Journal:  Cell Metab       Date:  2017-11-16       Impact factor: 27.287

3.  Adipocyte-specific DKO of Lkb1 and mTOR protects mice against HFD-induced obesity, but results in insulin resistance.

Authors:  Yan Xiong; Ziye Xu; Yizhen Wang; Shihuan Kuang; Tizhong Shan
Journal:  J Lipid Res       Date:  2018-04-10       Impact factor: 5.922

4.  Proteome and Phosphoproteome Analysis of Brown Adipocytes Reveals That RICTOR Loss Dampens Global Insulin/AKT Signaling.

Authors:  Samuel W Entwisle; Camila Martinez Calejman; Anthony S Valente; Robert T Lawrence; Chien-Min Hung; David A Guertin; Judit Villén
Journal:  Mol Cell Proteomics       Date:  2020-03-31       Impact factor: 5.911

Review 5.  Regulation and metabolic functions of mTORC1 and mTORC2.

Authors:  Angelia Szwed; Eugene Kim; Estela Jacinto
Journal:  Physiol Rev       Date:  2021-02-18       Impact factor: 46.500

6.  Age-dependent loss of adipose Rubicon promotes metabolic disorders via excess autophagy.

Authors:  Tadashi Yamamuro; Tsuyoshi Kawabata; Atsunori Fukuhara; Shotaro Saita; Shuhei Nakamura; Hikari Takeshita; Mari Fujiwara; Yusuke Enokidani; Gota Yoshida; Keisuke Tabata; Maho Hamasaki; Akiko Kuma; Koichi Yamamoto; Iichiro Shimomura; Tamotsu Yoshimori
Journal:  Nat Commun       Date:  2020-08-18       Impact factor: 17.694

7.  RNA based individualized drug selection in breast cancer patients without patient-matched normal tissue.

Authors:  Michael Forster; Adam Mark; Friederike Egberts; Elisa Rosati; Elke Rodriguez; Martin Stanulla; Dirk Bauerschlag; Christian Schem; Nicolai Maass; Anu Amallraja; Karla K Murphy; Bruce R Prouse; Raed A Sulaiman; Brandon M Young; Micaela Mathiak; Georg Hemmrich-Stanisak; David Ellinghaus; Stephan Weidinger; Philip Rosenstiel; Norbert Arnold; Brian Leyland-Jones; Casey B Williams; Andre Franke; Tobias Meißner
Journal:  Oncotarget       Date:  2018-08-17

8.  Non-canonical mTORC2 Signaling Regulates Brown Adipocyte Lipid Catabolism through SIRT6-FoxO1.

Authors:  Su Myung Jung; Chien-Min Hung; Samuel R Hildebrand; Joan Sanchez-Gurmaches; Barbara Martinez-Pastor; Jivani M Gengatharan; Martina Wallace; Dimpi Mukhopadhyay; Camila Martinez Calejman; Amelia K Luciano; Wen-Yu Hsiao; Yuefeng Tang; Huawei Li; Danette L Daniels; Raul Mostoslavsky; Christian M Metallo; David A Guertin
Journal:  Mol Cell       Date:  2019-08-22       Impact factor: 17.970

9.  Cardiac natriuretic peptides promote adipose 'browning' through mTOR complex-1.

Authors:  Dianxin Liu; Ryan P Ceddia; Sheila Collins
Journal:  Mol Metab       Date:  2018-01-17       Impact factor: 7.422

Review 10.  mTORC1 Overactivation as a Key Aging Factor in the Progression to Type 2 Diabetes Mellitus.

Authors:  Carlos Guillén; Manuel Benito
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-16       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.